Logo

Agencourt Bioscience Inks Distribution Pacts for Pacific, Asia, and Europe

Jan 21, 2004

NEW YORK, Jan. 21 (GenomeWeb News) - Agencourt Bioscience of Beverly, Mass., today announced a series of agreements to market for its nucleic acid purification chemistry products into countries in the Pacific, Asia, and Europe.

 

The company said it has signed distributions agreements with GenWorks for Australia and New Zealand; Bluestar for India; Pharmatech for  Korea; BioLaboratories for Singapore; and Genetic Research Instrumentation for the U.K and France.

 

Financial details were not disclosed.

Breaking News
The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.